Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep:195:106882.
doi: 10.1016/j.phrs.2023.106882. Epub 2023 Aug 3.

New therapies towards a better glycemic control in youths with type 1 diabetes

Roque Cardona-Hernandez  1 , Klemen Dôvc  2 , Torben Biester  3 , Laya Ekhlaspour  4 , Maddalena Macedoni  5 , Martin Tauschmann  6 , Chiara Mameli  7
Affiliations
Review

New therapies towards a better glycemic control in youths with type 1 diabetes

Roque Cardona-Hernandez et al. Pharmacol Res. 2023 Sep.

Erratum in

Abstract

Type 1 diabetes (T1D) is the most frequent form of diabetes in pediatric age, affecting more than 1.5 million people younger than age 20 years worldwide. Early and intensive control of diabetes provides continued protection against both microvascular and macrovascular complications, enhances growth, and ensures normal pubertal development. In the absence of definitive reversal therapy for this disease, achieving and maintaining the recommended glycemic targets is crucial. In the last 30 years, enormous progress has been made using technology to better treat T1D. In spite of this progress, the majority of children, adolescents and young adults do not reach the recommended targets for glycemic control and assume a considerable burden each day. The development of promising new therapeutic advances, such as more physiologic insulin analogues, pioneering diabetes technology including continuous glucose monitoring and closed loop systems as well as new adjuvant drugs, anticipate a new paradigm in T1D management over the next few years. This review presents insights into current management of T1D in youths.

Keywords: Automated insulin delivery; Children; Technology; Time in range; Type 1 diabetes; Youths.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest CM and MM declared no conflict of interest.

References

    1. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al., Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012, N. Engl. J. Med 376 (15) (2017) 1419–1429. - PMC - PubMed
    1. Magliano D, Boyko EJ IDF diabetes atlas, 10th ed., International Diabetes Federation, Brussels, 2021. - PubMed
    1. Gregory GA, Robinson TIG, Linklater SE, Wang F, Colagiuri S, de Beaufort C, et al., Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study, Lancet Diabetes Endocrinol. 10 (10) (2022) 741–760. - PubMed
    1. DCCT Group. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med 329 (14) (1993) 977–986. Available from: 10.1056/NEJM199309303291401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=www.ncbi.nlm.nih.gov. - DOI - PubMed
    1. Nathan DM, Bayless M, Cleary P, Genuth S, Gubitosi-Klug R, Lachin JM, et al., Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions, Diabetes 62 (12) (2013) 3976–3986. - PMC - PubMed